ArticleGynecologic oncology reports2022

Complete response to pembrolizumab in a patient with dermatomyositis and MMR deficient ovarian cancer: A case report.

Maia L Valls et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.